Clinical Trial Update: S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial S0232 assessed dexamethasone with or without lenalidomide in previously untreated Stage I–III multiple myeloma. The study results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Multiple Myeloma, Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2013-07-17